ESR1 and breast carcinoma: Triple-negative breast cancer (TNBC) accounts for 10–15% of all breast cancers (BC) and is defined by the absence of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression.